| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |